Portage Biotech Announces Upcoming PORT-2 Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting Life Science Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy Pharmaceutical Investing
Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production Pharmaceutical Investing
Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326 Company News
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting Pharmaceutical Investing
